CONGJING Group moxibustion instrument again obtained the second class medical device certificate of the Food and Drug Administration

Recently, two innovative "acupuncture moxibustion instrument" products of Conjing Group were approved by the Jiangsu Provincial Drug Administration for the second class medical device registration certificate (Registration certificate number: Su Shi Injection permit 20232091264, Su Shi injection permit 20232091268). This is following the CJ1001-I moxibustion instrument products last year, from the Jing Group approved the new portable ultra-short wave therapy instrument, through the combination of radio frequency technology and traditional Chinese medicine treatment theory, will effectively unlock the neck, shoulder, waist and leg pain and other "big problems", to make an important contribution to the improvement of the national health level.

In recent years, China's medical device industry has developed rapidly, with a compound annual growth rate of 10.54% in the past five years, and has become the world's second largest market for medical devices. In this process, innovative devices and high-end devices continue to be approved, and the device access and regulatory system are also constantly improving.

At the beginning of July, The State Council Information Office held a series of themed press conferences of "authoritative department talk opening", and Xu Jinghe, deputy director of the State Drug Administration, said that in recent years, the State Drug Administration has strengthened the top-level design and promoted departmental collaboration. The State Drug Administration and multiple departments jointly issued the "14th Five-Year Plan for National Drug Safety and Promoting High-quality Development", which clearly defined the overall principles, goals and tasks for promoting the high-quality development of the medical device industry. With the Ministry of Industry and Information Technology, the National Health Commission and other departments jointly issued the "14th Five-Year Plan" medical equipment industry development Plan and other documents to form a policy synergy.

In recent years, Congjing Group, as a domestic cutting-edge medical device enterprise, has continued to increase research and development investment, and innovative devices and high-end devices continue to emerge. With the support of the policy, the vitality of Congjing in the field of "medical industry integration" innovative medical devices will continue to burst out!

From the industry side, the public's health awareness continues to increase, consumption picks up, the market demand for safe and effective physiotherapy equipment or continue to grow, from the scene series of products industry penetration is expected to gradually increase, while with industry standards and technology and other barriers thickening, a larger market share will be concentrated to the dominant brand enterprises.